Highbridge Capital Management’s Surmodics SRDX Stock Holding History

Highbridge Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-14,381	Closed	-$338K	–	1665
2016 Q2	$338K	Buy	+14,381	New	+$315K	0.01%	1011
2016 Q1	–	Sell	-10,015	Closed	-$203K	–	1791
2015 Q4	$203K	Buy	+10,015	New	+$213K	﹤0.01%	1350
2015 Q1	–	Sell	-9,885	Closed	-$219K	–	1571
2014 Q4	$219K	Buy	+9,885	New	+$209K	﹤0.01%	1039
2013 Q3	–	Sell	-13,173	Closed	-$264K	–	1505
2013 Q2	$264K	Buy	+13,173	New	+$330K	﹤0.01%	1085

Other funds holding SRDX

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Highbridge Capital Management's SRDX Position: Q3 2016 in Review

Highbridge Capital Management sold out of Surmodics (SRDX) in Q3 2016, closing a stake of 14,381 shares — an estimated $338K sold.

Highbridge Capital Management first reported a position in SRDX in Q2 2013 and held it in 4 quarters. The position peaked at $338K in Q2 2016. 128 funds tracked by Wall St. Rank hold SRDX as of Q3 2016.

Highbridge Capital Management reported no remaining Surmodics position as of Q3 2016 after selling out during the quarter.
Highbridge Capital Management sold 14,381 Surmodics shares in Q3 2016, an estimated $338K.
Highbridge Capital Management first reported a position in Surmodics in Q2 2013 and held it in 4 quarters.
Highbridge Capital Management's Surmodics position peaked at $338K in Q2 2016.
128 funds tracked by Wall St. Rank held Surmodics as of Q3 2016.

Based on Highbridge Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.